Notably, cytotoxicity mediated by CAR/CCR T cells was also significantly enhanced at 24 h in case of CD19+CD80highCD86high DLBCL cell line SU-DHL-10 compared with CAR (2nd Gen) and CAR (1st Gen) T cells. This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.